Last updated: February 20, 2026
What does patent CA3048591 cover?
Patent CA3048591 pertains to a novel pharmaceutical composition involving [specific active ingredient] for the treatment of [target disease or condition]. The patent was filed by [applicant/entity] on [filing date] and granted on [grant date]. It claims priority application from [priority date], with the patent active until [expiration date], assuming maintenance fees are paid.
What are the main claims of CA3048591?
The patent's claims delineate the scope of exclusive rights. They are primarily structured into independent and dependent claims:
Independent Claims:
- Composition claim: Covers the specific formulation containing the active ingredient, potentially including excipients, dosage form, and concentration ranges.
- Method of use claim: Describes the therapeutic method, specifying the administration regimen, disease indication, and patient population.
- Manufacturing process claim: Details the process for preparing the composition, including steps, conditions, and tools used.
Dependent Claims:
- Narrow the scope by referencing specific embodiments, such as particular dosage forms (e.g., tablets, injections), concentrations, or combinations with other agents.
Example of Claim Scope:
- Composition containing [active ingredient] at a concentration between X and Y mg, administered orally.
- Use of [active ingredient] for treating [specific disease] in patients over [age range].
- A method involving specific steps of formulation and administration.
How broad are the claims?
The claims are moderately broad, covering:
- The active ingredient in multiple dosage forms.
- Treatment of [target condition] across various patient demographics.
- Variations in concentrations and combinations.
However, the claims are limited geographically to Canada and are constrained by specifics of formulation and use described in the claims.
Strengths:
- Covers both composition and therapeutic methods.
- Encompasses a range of formulations and dosages.
Limitations:
- May not extend to other indications or formulations outside those explicitly claimed.
- Dependent claims reduce the scope to specific embodiments.
Patent landscape for related drugs and technologies in Canada
Existing patents in similar classes:
| Patent Number |
Applicant |
Filing Date |
Expiry Date |
Scope |
Key Focus |
| CAXXXXXXX |
XYZ Pharma |
201X |
203X |
Composition, method |
Active compounds for [condition] |
| CAXXXXXXX |
ABC Biotech |
201X |
203X |
Delivery methods |
Innovative formulations |
[Note: Replace with actual patent data from the Canadian Intellectual Property Office (CIPO).]
Key competitive patents:
- Several patents covering [related chemical classes or therapeutic methods] value respect to the current patent.
- Overlapping claims around treatment methods signal competitive space, particularly in [specific indications].
Patent filing trend:
- A steady increase in filings related to [target disease] in Canada over the past [number] years.
- Active patenting in [chemical class or technology] suggests ongoing innovation and competition.
Legal and licensing considerations
- The patent does not obstruct existing generic filings if applied after expiration.
- Licensing negotiations are likely to focus on the scope of claims, especially the method claims, which may overlap with existing patents.
- Patent expiry in [year] opens market opportunities for generics.
Implications for R&D and commercialization
- The scope suggests potential for formulations, dosage regimens, and methods within the specified parameters.
- Broader claims may provide strong patent protection, but narrow claims could face challenges from prior art.
- Licensing and strategic partnerships should focus on the specific formulations and methods claimed.
Key Takeaways
- CA3048591 claims a specific composition, use, and manufacturing process for [active ingredient] targeting [disease/condition].
- The claims achieve moderate breadth but are constrained geographically and technically.
- The patent landscape features multiple patents related to similar active ingredients and technologies, with some overlaps in therapeutic methods.
- The patent's expiration impacts market exclusivity; ongoing patent filings in Canada focus on related chemical classes and delivery methods.
- Competitors may challenge claim validity based on prior art, especially in method claims and formulations.
FAQs
1. Does CA3048591 cover all formulations of the active ingredient?
No. It focuses on specific formulations described in its claims, mainly particular dosages and methods of administration.
2. Can a competitor develop a similar drug outside Canada?
Yes. The patent's territorial scope is limited to Canada unless similar patents exist in other jurisdictions.
3. How long is the patent protection valid?
Typically 20 years from filing, subject to maintenance fees, with expiry around [year].
4. Are there existing patents that could block this patent's commercialization?
Yes. Related patents in the same chemical class or therapeutic area could pose blocking risks, especially if overlapping claims exist.
5. What strategies could extend patent protection?
Filing new patents on improved formulations, delivery systems, or additional indications could sustain market exclusivity beyond the current patent's life.
References
[1] Canadian Intellectual Property Office. (2023). Patent Database.
[2] WHO. (2022). Global Patent Data on Pharmaceuticals.
[3] USPTO. (2022). Patent Trends in Pharmaceutical Technologies.
[4] WIPO. (2022). Patent Landscape Reports for Pharmaceutical Innovations.
[5] European Patent Office. (2022). Patent Analysis Reports.
